Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

in response to

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

BearDownAZ

posted on Sep 28, 2022 04:22PM

So is this new trial replacing BETonMACE2, or are both trials still planned?

Maybe they are morphing BETonMACE2 into this new trial, with a focus on diabetic and/or CKD patients post-Covid?

And if this new trial is focusing on diabetic patients, are they planning on treating w/ just apabetalone or also with SGLT2 inhibitor, DPP4 inhibitor, or GLP1R-agonist (I can't remember off hand which drug combos showed synergy).